AUA Guidelines for Hypogonadism: Diagnostic and Management Summary
The diagnosis of hypogonadism requires BOTH a total testosterone level consistently <300 ng/dL on two separate early morning measurements AND the presence of clinical symptoms and/or signs 1.
Diagnostic Algorithm
Step 1: Initial Testosterone Testing
- Obtain two separate early morning total testosterone measurements using the same laboratory and methodology
- Both values must be <300 ng/dL to meet biochemical criteria 1
- Single measurements are insufficient for diagnosis
Step 2: Clinical Assessment
Key Symptoms to Identify:
- Reduced libido and erectile dysfunction changes
- Fatigue, reduced energy, and diminished endurance
- Decreased work/physical performance
- Depression, reduced motivation, poor concentration, impaired memory, irritability
- Infertility
- Visual field changes (bitemporal hemianopsia) or anosmia 1
Physical Examination Findings:
- Body habitus and virilization status (body hair patterns in androgen-dependent areas)
- BMI or waist circumference measurement
- Gynecomastia presence
- Testicular evaluation: presence, size, consistency, masses
- Varicocele detection
- Prostate size and morphology 1
Step 3: High-Risk Populations Requiring Screening
Measure testosterone even WITHOUT symptoms in patients with:
- Unexplained anemia
- Bone density loss
- Diabetes
- Chemotherapy exposure
- Testicular radiation (direct or scatter)
- HIV/AIDS
- Chronic narcotic use
- Male infertility
- Pituitary dysfunction
- Chronic corticosteroid use 1
This represents a critical clinical pearl—these conditions warrant proactive screening regardless of symptom presence.
Adjunctive Testing Protocol
Step 4: Luteinizing Hormone (LH) Measurement
- Measure serum LH in ALL patients with confirmed low testosterone 1
- LH levels establish the etiology:
- Low or low-normal LH = secondary (hypogonadotropic) hypogonadism
- Elevated LH = primary (hypergonadotropic) hypogonadism
- Low/normal LH patients are candidates for selective estrogen receptor modulator therapy, particularly when fertility preservation is desired 1
Step 5: Prolactin Assessment
- Measure serum prolactin in patients with low testosterone AND low/low-normal LH 1
- Persistently elevated prolactin of unknown etiology mandates evaluation for endocrine disorders (pituitary adenoma, hypothyroidism, medications) 1
Important Caveats
Validated questionnaires should NOT be used to define candidates for testosterone therapy or monitor treatment response—they lack adequate specificity and sensitivity and should never replace proper laboratory testing and clinical evaluation 1.
The AUA differs from some other societies (EAU, Endocrine Society) on nomenclature and specific cutoffs, with the AUA preferring "testosterone deficiency" terminology and the 300 ng/dL threshold 2, 3. However, the core principle remains consistent: biochemical confirmation plus clinical manifestations are both mandatory for diagnosis.